Biotechnology News and Press Releases

Biotechnology

Releases published in the last 30 days.

Page 1 of 1

UPM Supports the Baltic Sea Action Group’s Operations to Prevent Eutrophication: 3/22/2019 12:35:22 PM; UPM continues its long-standing co-operation with the Baltic Sea Action Group (BSAG) to prevent eutrophication in the Baltic Sea and in Finnish waters. "Preventing eutrophication requires collaboration between various parties.
Health Hazard Evaluation of Bullet Manufacturer Finds High Rate of Lead Exposure Among Employees: 3/19/2019 10:30:40 AM; Last year, the National Institute for Occupational Safety and Health (NIOSH) released a Health Hazard Evaluation (HHE) that examined lead poisoning risks of workers at a lead bullet manufacturer.
CDC Guidance on Lyme Rash Challenged: 3/19/2019 9:00:00 AM; Advocates for Lyme disease patients have filed an “information quality request for correction” complaint that challenges the Centers for Disease Control and Prevention’s (CDC’s) position on how frequently the bull’s-eye erythema migrans (EM) rash occurs in patients with Lyme disease.
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis: 3/18/2019 6:19:05 AM; The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis (IPF), a type of lung disease that results in scarring (fibrosis) of the lungs.
Sanofi Successfully Prices EUR 2 Billion of Bond Issues: 3/15/2019 12:43:39 PM; Sanofi announces that it has successfully priced its offering of EUR 2 billion of notes (the “Notes”) across 3 tranches: •€850 million fixed rate notes, due March 2022, bearing interest at an annual rate of 0.0% •€650 million fixed rate notes, due March 2029, bearing interest at an annual rate of 0.875% •€500 million fixed rate notes, due March 2034, bearing interest at an …
Mammoth Biosciences Secures Exclusive License to Commercialize Novel CRISPR Protein: 3/14/2019 3:33:00 PM; Mammoth Biosciences, the company behind the world’s first CRISPR-based disease detection platform, announces the exclusive licensing of a new CRISPR protein, Cas14, from UC Berkeley, for use in all fields.
Government Agency Says Improved Asbestos-Related Data Would Enhance Oversight Ability: 3/14/2019 11:03:37 AM; This past December, the U.S. Government Accountability Office (GAO) publicly released Asbestos in GSA Buildings: Improved Data Would Enhance Oversight.
Wood to Construct Biofuel Facility in Oregon: 3/12/2019 7:49:36 PM; Wood has secured a multimillion dollar construction contract from IR1 Group LLC, which is building the Red Rock Biofuels facility in Lakeview, Oregon. Wood is contracted to provide construction and mechanical services.
Employees of Dental Office and Laboratories in California Advised of Potential Occupational Exposure Hazards: 3/11/2019 10:33:31 AM; There are over 30,000 dentists licensed to practice in California. Most of these licensed practitioners work alongside tens of thousands of dental hygienists, laboratory technicians and office staff.
Mission Bio Launches Tapestri® Designer, the First Automated On-Demand Cloud Tool for Targeted Single-Cell DNA Custom Panels: 3/7/2019 3:24:52 PM; Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced the launch of Tapestri Designer, the first-ever automated, cloud-based tool for designing targeted single-cell DNA custom panels.
Surgeon General Posts E-Cigarette Advisory Warning of Aerosol Exposures for Users and Bystanders: 3/7/2019 1:20:17 PM; This past December, U.S. Surgeon General Dr. Jerome Adams issued only his second advisory of his tenure. Surgeon General’s Advisory on E-cigarette Use Among Youth warns of the epidemic of youth e-cigarette use as well as aerosols that both users and bystanders could be exposed to due to these devices.
Accenture to Acquire ESP to Help Life Sciences Clients Digitize and Transform Manufacturing Operations: 3/5/2019 2:51:49 PM; Accenture (NYSE: ACN) has agreed to acquire Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland, serving clients around the globe.
Springer Nature expands its nanotechnology research solution with the inclusion of over 22 million patents: 2/28/2019 10:31:23 AM; A new module has now been added to the nanotechnology research database Nano. The patent module allows users to sort through over 22 million nano-related patents across all major jurisdictions and languages.
UPM Paid EUR 62 Million as Incentives to Employees in 2018: 2/28/2019 7:39:36 AM; UPM paid a total of EUR 62 million as short-term incentives to employees in 2018. The incentives were paid for the good 2017 results. The figures are outlined in UPM’s Annual Report that was published today.
New NIOSH Dampness and Mold Assessment Tool for General Buildings: 2/26/2019 11:55:50 AM; In December of last year, the National Institute for Occupational Safety and Health (NIOSH) announced it had developed a Dampness and Mold Assessment Tool for General Buildings.
Sight Diagnostics Named To Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019: 2/25/2019 1:07:34 PM; On February 20, 2019, Fast Company announced the winners of its prestigious annual list, the World’s Most Innovative Companies for 2019, which honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world.